"Adding YUSIMRY, a biosimilar of Humira, to Cost Plus Drugs will extend ... ever-evolving environment with the goals of sustainable prescription drug spend, improved member access, and ...

Medically reviewed by Shadi Hamdeh, MDMedically reviewed by Shadi Hamdeh, MD Humira (adalimumab) side effects may include ...

Net costs per prescription also declined precipitously, by 43%, the group reported in a JAMA Health Forum research letter. But Humira also retained its stranglehold on the market for adalimumab ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread ...

AVOS Life Sciences has analysed the revenue contributions of biologics and small-molecule drugs to the major Rx drug portfolios ... consists of a single drug, adalimumab (Humira), the consensus ...

Of the amount earned in 2024, $1.6 million came from Michael’s salary, which increased a little less than $200,000 compared with 2023 as part of his promotion, AbbVie said in its 2025 proxy ...

SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), today announced a major expansion to its Connect 360 Autoimmune Program, including the introduction of Stelara ...